CANDEL THERAPEUTICS INC (CADL) Stock Analyst Earnings Estimates
NASDAQ:CADL - Nasdaq - US1374041093 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 125K | 125K | 125K | -100.00% | 49.463M | 373.02M 654.14% | 836.33M 124.21% | 1.406B 68.12% | ||||
| EBITDA YoY % growth | -13.719M -52.54% | -25.494M -85.83% | -33.944M -33.15% | -34.996M -9.09% | -35.067M 12.56% | -37.895M -17.03% | -52.265M -37.92% | -21.882M 58.13% | 258.8M 1,282.69% | 689.98M 166.61% | 1.224B 77.40% | |
| EBIT YoY % growth | -13.81M -52.82% | -25.726M -86.29% | -34.722M -34.97% | -38.046M -9.41% | -35.512M 12.16% | -38.199M -14.47% | -51.818M -35.65% | -28.617M 44.77% | 257.75M 1,000.68% | 688.92M 167.28% | 1.223B 77.52% | |
| Operating Margin | -11,048.00% | -20,580.80% | -27,777.60% | N/A | N/A | N/A | N/A | -57.86% | 69.10% | 82.37% | 86.98% | |
| EPS YoY % growth | N/A | N/A | -1.12 46.21% | -1.11 -21.43% | -1.40 -2.69% | -0.83 40.22% | -1.34 -60.66% | -0.64 52.21% | N/A | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.24 | -0.24 | -0.30 24.88% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | -9.912M -22.81% | -10.569M -31.91% | -10.703M -49.67% |
| EBIT Q2Q % growth | -9.692M -13.08% | -10.36M -18.31% | -10.637M -30.65% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 0.13 | -0.31 | 0.44 | 142.48% |
| Q4 2024 Q2Q % growth | -0.40 -5.26% | -0.23 | -0.17 | -72.38% |
| Q4 2023 Q2Q % growth | -0.38 -111.11% | -0.16 | -0.22 | -132.84% |
| Q3 2023 Q2Q % growth | -0.31 -3.33% | -0.19 | -0.12 | -59.96% |
| Q2 2023 Q2Q % growth | -0.34 -6.25% | -0.30 | -0.04 | -11.67% |
| Q1 2023 Q2Q % growth | -0.33 -3.13% | -0.36 | 0.03 | 7.56% |
| Q4 2022 Q2Q % growth | -0.18 -158.06% | -0.32 | 0.14 | 43.44% |
| Q3 2022 Q2Q % growth | -0.30 -15.38% | -0.36 | 0.06 | 16.68% |
| Q2 2022 Q2Q % growth | -0.32 -3.23% | -0.42 | 0.10 | 23.01% |
| Q1 2022 Q2Q % growth | -0.32 | -0.31 | -0.01 | -1.86% |
| Q4 2021 Q2Q % growth | 0.31 | -0.33 | 0.64 | 194.98% |
| Q3 2021 Q2Q % growth | -0.26 | -0.30 | 0.04 | 12.10% |
| Q2 2021 Q2Q % growth | -0.31 | -0.12 | -0.19 | -153.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | 31K | 23.123K | 7.877K | 34.06% |
| Q3 2022 Q2Q % growth | 31K | 30.6K | 400 | 1.31% |
| Q2 2022 Q2Q % growth | 31K | 31K | % | |
| Q1 2022 Q2Q % growth | 31K | 15.3K | 15.7K | 102.61% |
| Q4 2021 Q2Q % growth | 31K | 15.3K | 15.7K | 102.61% |
| Q3 2021 Q2Q % growth | 31K | 40.8K | -9.8K | -24.02% |
| Q2 2021 Q2Q % growth | 31K | 20.4K | 10.6K | 51.96% |
| Q1 2021 Q2Q % growth | 31K | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.54% | 41.5% | 15.15% | 41.03% |
| Revenue | N/A | N/A | N/A | N/A |